AI and polygenic scores improve breast cancer risk assessment
A risk model that combines a mammographic artificial intelligence (AI) risk score with polygenic and clinical risk scores more accurately identifies women at high risk of developing breast cancer than clinical risk scores used alone, finds a new Kaiser Permanente study. The study